Cargando…

Optimization of Potent and Selective Quinazolinediones: Inhibitors of Respiratory Syncytial Virus That Block RNA-Dependent RNA-Polymerase Complex Activity

[Image: see text] A quinazolinedione-derived screening hit 2 was discovered with cellular antiviral activity against respiratory syncytial virus (CPE EC(50) = 2.1 μM), moderate efficacy in reducing viral progeny (4.2 log at 10 μM), and marginal cytotoxic liability (selectivity index, SI ∼ 24). Scaff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matharu, Daljit S., Flaherty, Daniel P., Simpson, Denise S., Schroeder, Chad E., Chung, Donghoon, Yan, Dan, Noah, James W., Jonsson, Colleen B., White, E. Lucile, Aubé, Jeffrey, Plemper, Richard K., Severson, William E., Golden, Jennifer E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2014
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281105/ https://www.ncbi.nlm.nih.gov/pubmed/25399509 http://dx.doi.org/10.1021/jm500902x

Ejemplares similares

A cell based high-throughput screening approach for the discovery of new inhibitors of respiratory syncytial virus
por: Chung, Dong-Hoon, et al.
Publicado: (2013)

Rational Design and Lead Optimisation of Potent Antimalarial Quinazolinediones and Their Cytotoxicity against MCF-7
por: Charoensutthivarakul, Sitthivut, et al.
Publicado: (2023)

Development of (E)-2-((1,4-Dimethylpiperazin-2-ylidene)amino)-5-nitro-N-phenylbenzamide, ML336: Novel 2-Amidinophenylbenzamides as Potent Inhibitors of Venezuelan Equine Encephalitis Virus
por: Schroeder, Chad E., et al.
Publicado: (2014)

Potent Host-Directed Small-Molecule Inhibitors of Myxovirus RNA-Dependent RNA-Polymerases
por: Krumm, Stefanie A., et al.
Publicado: (2011)

Antitarget Interaction, Acute Toxicity and Protein Binding Studies of Quinazolinedione Sulphonamides as GABA(1) Antagonists
por: Ajeet,, et al.
Publicado: (2016)

Bypassing Fluoroquinolone Resistance with Quinazolinediones: Studies of Drug–Gyrase–DNA Complexes Having Implications for Drug Design
por: Drlica, Karl, et al.
Publicado: (2014)

Alkylation of 2,4-(1H,3H)-Quinazolinediones with Dialkyl Carbonates Under Microwave Irradiations
por: Rivero, Ignacio Alfredo, et al.
Publicado: (2009)

Organization, Function, and Therapeutic Targeting of the Morbillivirus RNA-Dependent RNA Polymerase Complex
por: Sourimant, Julien, et al.
Publicado: (2016)

Synthesis of 3-N-Sugar-substituted-2, 4(1H, 3H)-quinazolinediones as Anti-Angiogenesis Agents
por: Huang, Conghai, et al.
Publicado: (2009)

RNA elongation by respiratory syncytial virus polymerase is calibrated by conserved region V
por: Braun, Molly R., et al.
Publicado: (2017)

Repositioning of Quinazolinedione-Based Compounds on Soluble Epoxide Hydrolase (sEH) through 3D Structure-Based Pharmacophore Model-Driven Investigation
por: Gazzillo, Erica, et al.
Publicado: (2022)

Development and Validation of a High-Throughput Screen for Inhibitors of SARS CoV and Its Application in Screening of a 100,000-Compound Library
por: Severson, William E., et al.
Publicado: (2007)

Cryo-EM structure of the respiratory syncytial virus RNA polymerase
por: Cao, Dongdong, et al.
Publicado: (2020)

Analysis of Template Variations on RNA Synthesis by Respiratory Syncytial Virus Polymerase
por: Cao, Dongdong, et al.
Publicado: (2022)

Conserved allosteric inhibitory site on the respiratory syncytial virus and human metapneumovirus RNA-dependent RNA polymerases
por: Kleiner, Victoria A., et al.
Publicado: (2023)

The Respiratory Syncytial Virus Polymerase Has Multiple RNA Synthesis Activities at the Promoter
por: Noton, Sarah L., et al.
Publicado: (2012)

Biochemistry of the Respiratory Syncytial Virus L Protein Embedding RNA Polymerase and Capping Activities
por: Sutto-Ortiz, Priscila, et al.
Publicado: (2023)

Potent inhibition of microRNA in vivo without degradation
por: Davis, Scott, et al.
Publicado: (2009)

Orally efficacious lead of the AVG inhibitor series targeting a dynamic interface in the respiratory syncytial virus polymerase
por: Sourimant, Julien, et al.
Publicado: (2022)

Therapeutic targeting of measles virus polymerase with ERDRP-0519 suppresses all RNA synthesis activity
por: Cox, Robert M., et al.
Publicado: (2021)

Time to ‘Mind the Gap’ in novel small molecule drug discovery for direct-acting antivirals for SARS-CoV-2
por: Jonsson, Colleen B, et al.
Publicado: (2021)

Engineered mRNA-expressed antibodies prevent respiratory syncytial virus infection
por: Tiwari, Pooja Munnilal, et al.
Publicado: (2018)

Editorial overview: Antiviral strategies: Antiviral drug development for single-stranded RNA viruses
por: Brinton, Margo A, et al.
Publicado: (2019)

MOV10 RNA Helicase Is a Potent Inhibitor of Retrotransposition in Cells
por: Goodier, John L., et al.
Publicado: (2012)

Structural Insights into the Respiratory Syncytial Virus RNA Synthesis Complexes
por: Cao, Dongdong, et al.
Publicado: (2021)

Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones
por: Ryan, Michael C., et al.
Publicado: (2022)

The respiratory syncytial virus nucleoprotein–RNA complex forms a left-handed helical nucleocapsid
por: Bakker, Saskia E., et al.
Publicado: (2013)

Baicalin Induces a Potent Innate Immune Response to Inhibit Respiratory Syncytial Virus Replication via Regulating Viral Non-Structural 1 and Matrix RNA
por: Qin, Sheng, et al.
Publicado: (2022)

Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection
por: Detalle, Laurent, et al.
Publicado: (2015)

Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus
por: Marcandalli, Jessica, et al.
Publicado: (2019)

Potent anti-tumor effects of receptor-retargeted syncytial oncolytic herpes simplex virus
por: Suzuki, Takuma, et al.
Publicado: (2021)

In vitro trackable assembly of RNA-specific nucleocapsids of the respiratory syncytial virus
por: Gao, Yunrong, et al.
Publicado: (2020)

Benzimidazole analogs inhibit respiratory syncytial virus G protein function
por: Evans, Carrie W., et al.
Publicado: (2015)

The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus
por: Gordon, Calvin J., et al.
Publicado: (2020)

Parent tRNA Modification Status Determines the Induction of Functional tRNA-Derived RNA by Respiratory Syncytial Virus Infection
por: Choi, Eun-Jin, et al.
Publicado: (2022)

Respiratory Syncytial Virus
por: Fraire, Armando E., et al.
Publicado: (2013)

The transcript cleavage factor paralogue TFS4 is a potent RNA polymerase inhibitor
por: Fouqueau, Thomas, et al.
Publicado: (2017)

A Pan-GTPase Inhibitor as a Molecular Probe
por: Hong, Lin, et al.
Publicado: (2015)

A minimal RNA ligand for potent RIG-I activation in living mice
por: Linehan, Melissa M., et al.
Publicado: (2018)

Molecular Basis for the Selective Inhibition of Respiratory Syncytial Virus RNA Polymerase by 2'-Fluoro-4'-Chloromethyl-Cytidine Triphosphate
por: Deval, Jerome, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_odm0av3sc2a4b57c8kdrplon72